check_circleStudy Completed

Candidiasis, Vulvovaginal

Bayer Identifier:

Trial_0583

ClinicalTrials.gov Identifier:

Not Available

EudraCT Number:

Not Available

EU CT Number:

Not Available
Clotrimazole vaginal tablets 100 mg (galenic formulation with lactic acid) in 6-day therapy in vaginal candida infections

Trial purpose

Please see attached Study Results Summary below.

Key Participants Requirements

Sex

Female

Age

17 - 60 Years
  • -

  • -

Trial summary

Enrollment Goal
42
Trial Dates
November 1984 - April 1985
Phase
Phase 2
Could I Receive a placebo
N/A
Products
Mycelex (Clotrimazole, BAYB5097)
Accepts Healthy Volunteer
N/A

Trial design

Efficacy and tolerability of clotrimazole vaginal tablets 100 mg (galenic formulation with lactic acid) in 6-day therapy in vaginal candida infections
Trial Type
Interventional
Intervention Type
N/A
Trial Purpose
N/A
Allocation
N/A
Blinding
N/A
Assignment
N/A
Trial Arms
N/A

Additional Information

Click here and search for drug information provided by the FDA.Click here and search for information on any recalls, market or product safety alerts by the FDA which might have occurred with this product.Click here to find results for studies related to marketed products.